The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Cell. Infect. Microbiol.
Sec. Biofilms
Volume 15 - 2025 |
doi: 10.3389/fcimb.2025.1566230
This article is part of the Research Topic Understanding Biofilms: Recent Trends and Developments View all 6 articles
Editorial: Understanding Biofilms: Recent Trends and Developments
Provisionally accepted- 1 Centre for biotechnology, Siksha O Anusandhan University, Bhubaneswar, India
- 2 Universidade Ceuma, São Luís, Maranhão, Brazil
Biofilms are intricate microbial communities that adhere to surfaces encased in a selfproduced extracellular matrix (Sahoo et al., 2021). These structures are prevalent in natural, industrial, and clinical environments, posing significant challenges and opportunities for scientific research and practical applications. Biofilms are not merely clusters of microorganisms; they are highly organized communities exhibiting unique phenotypic traits distinct from their planktonic counterparts. Their ability to resist antimicrobial treatments and evade the host immune system makes them formidable adversaries in clinical settings. Biofilm-associated infections are implicated in a substantial proportion of chronic diseases, including those involving medical devices, chronic wounds, and respiratory tract infections.The special topic "Understanding Biofilms: Recent Trends and Developments," published in Frontiers in Cellular and Infection Microbiology, showcases cutting-edge research to unravel the complexities of biofilm formation, persistence, and control. The five articles in this unique topic address various aspects of biofilm research, from fundamental biological mechanisms to translational and applied studies, with a particular focus on the ESKAPEE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli). Because ESKAPEE group of pathogens can create biofilms that are roughly 1,000 times more resistant to antimicrobials than planktonic cells, treating them is especially difficult (Panda et al., 2022). Innovative strategies are urgently required to address infections caused by multidrug-resistant (MDR) pathogens (Panda et al., 2021;Tiwari et al., 2023).One of the key themes explored in this collection is the molecular and genetic basis of biofilm formation. Understanding the regulatory networks and signaling pathways that govern biofilm development is crucial for identifying potential targets for therapeutic where authors followed bioassay-guided purification and identified the compound as hydroquinone with the help of LC-MS and NMR. But later, authors realize this is not the actual compound. Rather, the antimicrobial activity is due to the oxidation product of benzoquinone. By adding antioxidants, the authors inhibit the oxidation to confirm that the hydroquinone lost its activity in the presence of antioxidants at different pH conditions. This research provides valuable insights into the antibiofilm activity by elucidating the role of benzoquinone, the oxidation product of hydroquinone, as the primary active compound. The authors conclude that all earlier reports on the bioactivity of hydroquinone may need to be re-evaluated in light of the published results. formulations on periodontal biofilm-immune cell interactions. This research provides valuable insights into the potential of HA as a therapeutic agent in periodontal disease, demonstrating its ability to modulate inflammatory responses and influence biofilm formation. These findings contribute to a better understanding of the complex interplay between host immune responses and bacterial biofilms in the oral cavity.The contributions to this special topic underscore the importance of a multidisciplinary approach to understanding and managing biofilms. Integrating microbiology, immunology, chemistry, materials science, and clinical research is essential for developing effective strategies to prevent and treat biofilm-associated infections. With the continuous advancement in our understanding of biofilm biology, we are increasingly capable of formulating innovative strategies to address their associated challenges.In conclusion, the five published articles on "Understanding Biofilms: Recent Trends and Developments" reflect biofilm research's dynamic and evolving nature. They highlight significant advancements in our understanding of biofilm formation, the interactions between biofilms and the host immune system, and the development of novel therapeutic and preventive strategies. We hope this collection will inspire further research and collaboration in this critical area of microbiology, ultimately leading to improved outcomes for patients affected by biofilm-associated infections.We thank all the authors' excellent contributions, the reviewers and editors for their comments that improved all articles to this special topic. Their dedication and expertise have made this collection possible. We also thank the readers for their interest in this vital field of study. Together, we can continue to advance our understanding of biofilms and develop innovative solutions to their challenges.The present research topic thus includes interdisciplinary research work expanding the knowledge about antimicrobial resistance among biofilm. This research topic successfully gathered comprehensive information on the development of biofilm and recent strategies to combat biofilm.We hope this article collection will inspire scientists from different fields of research focusing on biofilm.
Keywords: antimicrobial resistance, Biofilm, ESKAPE, MRSA, Radioimmunotherapy
Received: 24 Jan 2025; Accepted: 28 Jan 2025.
Copyright: © 2025 Panda and da Silva. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Sujogya Kumar Panda, Centre for biotechnology, Siksha O Anusandhan University, Bhubaneswar, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.